The administration of anti-OX40L neutralizing antibody during primary RSV infection in neonatal mice prevented the subsequent enhancement of AHR and the development of airway eosinophilia and mucus hyperproduction upon re-infection. The gene discussed is TNFSF4; the disease is infection.